4163 Overzicht aandelen
Al-Dawaa Medical Services Company is, samen met haar dochterondernemingen, voornamelijk actief als farmaceutische detailhandel in het Koninkrijk Saoedi-Arabië.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 6/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 2/6 |
Al-Dawaa Medical Services Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ر.س86.50 |
| 52 Week Hoogtepunt | ر.س121.60 |
| 52 Week Laag | ر.س80.90 |
| Bèta | 0.013 |
| 11 maand verandering | -7.39% |
| 3 maanden verandering | 2.13% |
| 1 Jaar Verandering | -14.02% |
| 33 jaar verandering | n/a |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | 10.05% |
Recent nieuws en updates
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24
The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Recent updates
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger
Dec 26Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25
Sep 03Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing
Jul 13Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 22Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)
Apr 10Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio
Mar 14Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?
Dec 08Rendement voor aandeelhouders
| 4163 | SA Consumer Retailing | SA Markt | |
|---|---|---|---|
| 7D | -4.6% | -2.0% | 0.1% |
| 1Y | -14.0% | 1.9% | -9.5% |
Rendement versus industrie: 4163 underperformed the SA Consumer Retailing industry which returned 1.9% over the past year.
Rendement versus markt: 4163 underperformed the SA Market which returned -9.5% over the past year.
Prijsvolatiliteit
| 4163 volatility | |
|---|---|
| 4163 Average Weekly Movement | 3.5% |
| Consumer Retailing Industry Average Movement | 4.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in SA Market | 7.4% |
| 10% least volatile stocks in SA Market | 2.9% |
Stabiele aandelenkoers: 4163 has not had significant price volatility in the past 3 months compared to the SA market.
Volatiliteit in de loop van de tijd: 4163's weekly volatility (3%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Mohammed Saad Al-Farraj Al-Subaie | www.al-dawaa.com.sa |
Al-Dawaa Medical Services Company is, samen met haar dochterondernemingen, voornamelijk actief als farmaceutische detailhandel in het Koninkrijk Saoedi-Arabië. Het is actief in drie segmenten: Detailhandel, Groothandel en Logistiek. Het bedrijf biedt geneesmiddelen, parfums, cosmetica, schoonheidsmiddelen en -producten en andere farmaceutische producten aan.
Al-Dawaa Medical Services Company Samenvatting
| 4163 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ر.س7.35b |
| Inkomsten(TTM) | ر.س354.84m |
| Inkomsten(TTM) | ر.س6.00b |
20.7x
Koers/Winstverhouding1.2x
P/S-verhoudingIs 4163 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 4163 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ر.س6.00b |
| Kosten van inkomsten | ر.س3.86b |
| Brutowinst | ر.س2.14b |
| Overige uitgaven | ر.س1.79b |
| Inkomsten | ر.س354.84m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 4.17 |
| Brutomarge | 35.74% |
| Nettowinstmarge | 5.91% |
| Schuld/Eigen Vermogen Verhouding | 45.1% |
Hoe presteerde 4163 op de lange termijn?
Bekijk historische prestaties en vergelijking